Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study

Abstract

Our results indicate that even low-dose IFN-alpha induces cognitive impairment independent from depressive symptoms, which might be related to functional disturbances in the prefrontal cortex and the hippocampus. We suggest close monitoring of cognitive function during IFN-alpha treatment of chronic hepatitis.